AZD7442 Reduced Risk of Developing Severe COVID-19 or Death in TACKLE Phase III Outpatient Treatment Trial
This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
The CLL Society is fortunate to have Dr. John Pagel as a member of both our medical advisory board and our board of directors.
He is a sought-after expert on CLL and other blood cancers due to his research and his thoughtful and patient-first approach to issues.
While this article on Telemedicine during the COVID-19 pandemic is aimed at the professional medical community, it is easily accessible and valuable reading for any patient.
Takeaways:
- Come to the virtual visit prepared with a list of the issues to discuss.
- Limit lab work or schedule during a period of reduced traffic and flow of patients in and out of the laboratory.
- Consider therapies that can be managed at home.
Thank you, Dr. Pagel for alerting your colleagues to best practices in these unprecedented times.
Virtual visits do have their advantages.
The CLL Society was ahead of the curve with our 4-year history of providing free virtual online 2nd opinions from the comfort and safety of your home with CLL through our Expert Access Program. It is open now for anyone living in the USA with a CLL diagnosis who is not currently seeing an expert.
Thanks for reading
Brian Koffman
Related posts
